Kahlenberg, J. Michelle http://orcid.org/0000-0002-4006-8945
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24AR076975, r01AR071384)
Article History
First Online: 27 July 2021
Competing interests
: J.M.K. has received grant support from Q32 Bio, Celgene/BMS and Janssen. J.M.K. has served on advisory boards for AstraZeneca, Eli Lilly, GlaxoSmithKline, Bristol Myers Squibb, Avion Pharmaceuticals, Provention Bio, Aurinia Pharmaceuticals, Ventus Therapeutics and Boehringer Ingelheim.